We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $544M
1-Year Est. Return 72.49%
This Fund
S&P 500
This Quarter Est. Return
-23.9%
1 Year Est. Return
+72.49%
3 Year Est. Return
+451.42%
5 Year Est. Return
10 Year Est. Return
AUM
$302M
AUM Growth
-$151M
Cap. Flow
-$16.4M
Cap. Flow %
-5.44%
Top 10 Hldgs %
49.77%
Holding
317
New
38
Increased
51
Reduced
65
Closed
64

Top Buys

Rank Stock Value
1
SNOW icon
Snowflake
SNOW
+$3.72M
2
SHOP icon
Shopify
SHOP
+$3.18M
3
ADSK icon
Autodesk
ADSK
+$3.15M
4
CRM icon
Salesforce
CRM
+$2.94M
5
HTZWW
Hertz Global Holdings Warrants
HTZWW
+$2.55M

Sector Composition

Rank Sector Weight
1 Technology 27.72%
2 Healthcare 26.86%
3 Miscellaneous 22.85%
4 Communication Services 13.94%
5 Consumer Discretionary 5.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BREZW
176
DELISTED
Breeze Holdings Acquisition Corp. Warrant
BREZW
$7K ﹤0.01%
44,000
EACPW
177
DELISTED
Edify Acquisition Corp. Warrant
EACPW
$7K ﹤0.01%
61,130
KBNTW
178
DELISTED
Kubient, Inc. Warrant
KBNTW
$7K ﹤0.01%
25,587
-9,813
-28% -$2.99K
AGAC.WS
179
DELISTED
African Gold Acquisition Corp Warrants
AGAC.WS
$7K ﹤0.01%
84,495
MONCW
180
DELISTED
Monument Circle Acquisition Corp. Warrant
MONCW
$7K ﹤0.01%
71,666
COVAW
181
DELISTED
COVA Acquisition Corp. Warrants to purchase Class A ordinary shares
COVAW
$7K ﹤0.01%
66,392
FSSIW
182
DELISTED
Fortistar Sustainable Solutions Corp. Warrant
FSSIW
$7K ﹤0.01%
58,332
EQHA.WS
183
DELISTED
EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
$7K ﹤0.01%
73,900
ZFOXW
184
DELISTED
ZeroFox Holdings, Inc. Warrants
ZFOXW
$6K ﹤0.01%
39,450
CMRAW
185
DELISTED
Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027
CMRAW
$6K ﹤0.01%
+42,488
New +$6.96K
KLAQW
186
DELISTED
KL Acquisition Corp Warrant
KLAQW
$6K ﹤0.01%
38,399
SHACW
187
DELISTED
SCP & CO Healthcare Acquisition Company Warrant
SHACW
$6K ﹤0.01%
74,749
FTCVW
188
DELISTED
FinTech Acquisition Corp. V Warrant
FTCVW
$6K ﹤0.01%
64,657
-5,100
-7% -$2.56K
SWETW
189
DELISTED
Athlon Acquisition Corp. Warrant
SWETW
$6K ﹤0.01%
51,500
MDH.WS
190
DELISTED
MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
MDH.WS
$6K ﹤0.01%
71,400
TLGA.WS
191
DELISTED
TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TLGA.WS
$6K ﹤0.01%
70,400
CPTNW
192
DELISTED
Cepton, Inc. Warrant
CPTNW
$6K ﹤0.01%
50,000
-20,000
-29% -$5.78K
KRNLW
193
DELISTED
Kernel Group Holdings, Inc. Warrants
KRNLW
$5K ﹤0.01%
71,300
EVOJW
194
DELISTED
Evo Acquisition Corp. Warrant
EVOJW
$5K ﹤0.01%
71,650
AEACW
195
DELISTED
Authentic Equity Acquisition Corp. Warrant
AEACW
$5K ﹤0.01%
53,000
ASAXW
196
DELISTED
Astrea Acquisition Corp. Warrant
ASAXW
$5K ﹤0.01%
65,858
VENAR
197
DELISTED
Venus Acquisition Corporation Rights
VENAR
$5K ﹤0.01%
47,789
ACKIW
198
DELISTED
Ackrell SPAC Partners I Co Warrants
ACKIW
$5K ﹤0.01%
52,100
CXAIW icon
199
CXApp Inc Warrant
CXAIW
$671K
$4K ﹤0.01%
31,900
REVBW icon
200
Revelation Biosciences Warrant
REVBW
$4K ﹤0.01%
44,000

Similar funds

Privium Fund Management's Q2 2022 Portfolio in Review

As of Q2 2022, Privium Fund Management held 317 positions worth $302M, down 33% from $452M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Privium Fund Management withdrew a net $16.4M in Q2 2022, closing 64 positions and reducing 65 holdings. Its most notable exit was Royalty Pharma, an estimated $9.48M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Miscellaneous.

Against the trend, Privium Fund Management opened a new position in Microsoft worth $2.06M.

  • Privium Fund Management's largest Q2 2022 buy was Microsoft: 8,000 shares worth $2.06M.
  • Privium Fund Management added most to Snowflake in Q2 2022, an estimated $3.72M increase.
  • Privium Fund Management's biggest Q2 2022 reduction was argenx, cutting an estimated $4.12M.
  • Privium Fund Management fully exited Royalty Pharma in Q2 2022, selling an estimated $9.48M.
  • Privium Fund Management's ten largest holdings make up 50% of its $302M portfolio in Q2 2022.
  • Privium Fund Management opened 38 new positions and closed 64 in Q2 2022.
  • Privium Fund Management's portfolio value fell 33% quarter-over-quarter to $302M.

Based on Privium Fund Management's 13F filing for Q2 2022, filed 28 Jul 2022.